Eli Lilly and
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $11,439,100 | $11,302,800 | $8,768,000 | $9,353,400 |
Gross Profit | 9,268,300 | 9,132,600 | 7,233,600 | 7,694,400 |
EBITDA | 2,247,900 | 4,115,200 | 3,116,300 | 3,034,700 |
EBIT | 1,781,100 | 3,700,800 | 2,715,700 | 2,647,000 |
Net Income | 970,300 | 2,967,000 | 2,242,900 | 2,189,700 |
Net Change In Cash | 11,439,100 | 11,302,800 | 8,768,000 | 9,353,400 |
Free Cash Flow | -458,900 | 63,400 | 179,700 | -1,963,000 |
Cash | 3,369,000 | 3,223,600 | 2,460,200 | 2,818,600 |
Basic Shares | 905,000 | 904,200 | 903,802 | 949,379 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $34,124,100 | $28,541,400 | $28,318,400 | $24,539,800 |
Gross Profit | 27,041,900 | 21,911,600 | 21,005,600 | 19,056,500 |
EBITDA | 8,567,800 | 8,660,500 | 8,042,900 | 8,913,400 |
EBIT | 7,040,500 | 7,138,000 | 6,495,300 | 7,589,500 |
Net Income | 5,240,400 | 6,244,800 | 5,581,700 | 6,193,700 |
Net Change In Cash | 34,124,100 | 28,541,400 | 28,318,400 | 24,539,800 |
Cost of Revenue | -1,583,900 | |||
Free Cash Flow | -3,152,000 | 4,600,400 | 5,387,500 | 4,470,500 |
Cash | 2,818,600 | 2,067,000 | 3,818,500 | 3,657,100 |
Basic Shares | 903,284 | 904,619 | 911,681 | 912,505 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | $1.18 |
2024-06-30 | $3.92 |
2024-03-31 | $2.58 |
2023-12-31 | $2.49 |
